Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival
Open Access
- 1 February 2012
- journal article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 5 (Suppl 1), i52-i61
- https://doi.org/10.1093/ndtplus/sfr167
Abstract
Patients with chronic kidney disease (CKD) have a high prevalence of vascular calcification, and cardiovascular disease is the leading cause of death in this population. However, the molecular mechanisms of vascular calcification, which are multifactorial, cell-mediated and dynamic, are not yet fully understood. We need to address ways to improve outcomes in CKD patients, both in terms of vascular calcification and cardiovascular morbidity and mortality—and to these ends, we investigate the role of magnesium. Magnesium’s role in the pathogenesis of vascular calcification has not been extensively studied. Nonetheless, several in vitro and animal studies point towards a protective role of magnesium through multiple molecular mechanisms. Magnesium is a natural calcium antagonist and both human and animal studies have shown that low circulating magnesium levels are associated with vascular calcification. Clinical evidence from observational studies of dialysis patients has shown that low-magnesium levels occur concurrently with mitral annular calcification, peripheral arterial calcification and increased carotid intima–media thickness. Few interventional studies have been performed. Two interventional studies suggest that there may be benefits such as retardation of arterial calcification and/or reductions in carotid intima–media thickness in response to magnesium supplementation in CKD patients, though both studies have limitations. Finally, observational studies have shown that low serum magnesium may be an independent risk factor for premature death in CKD patients, and patients with mildly elevated serum magnesium levels could have a survival advantage over those with lower magnesium levels.Keywords
This publication has 79 references indexed in Scilit:
- Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent mannerNephrology Dialysis Transplantation, 2011
- Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitroKidney International, 2011
- Recent progress in the treatment of vascular calcificationKidney International, 2010
- Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patientsNephrology Dialysis Transplantation, 2010
- Ultrastructural Analysis of Vascular Calcifications in UremiaJournal of the American Society of Nephrology, 2010
- Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticumJournal of Molecular Medicine, 2010
- Chronic Mineral Dysregulation Promotes Vascular Smooth Muscle Cell Adaptation and Extracellular Matrix CalcificationJournal of the American Society of Nephrology, 2010
- Magnesium Carbonate‐Containing Phosphate Binder Prevents Connective Tissue Mineralization in Abcc6−/− Mice–Potential for Treatment of Pseudoxanthoma ElasticumClinical and Translational Science, 2009
- Coronary Calcification in Patients with Chronic Kidney Disease and Coronary Artery DiseaseClinical Journal of the American Society of Nephrology, 2009
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000